Sequella

About:

Sequella is a biopharmaceutical company developing products for the diagnosis and treatment of epedemic infectious diseases.

Website: http://www.sequella.com

Description:

Sequella is a clinical-stage biopharmaceutical company, develops products for the diagnosis and treatment of infectious diseases. The company focuses on commercializing treatment paradigms for diseases of epidemic potential. The company was founded in 1997 and headquartered in Rockville, Maryland.

Total Funding Amount:

$48.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Rockville, Maryland, United States

Founded Date:

1997-01-01

Contact Email:

mail(AT)sequella.com

Founders:

Carol Nacy, Leo Einck

Number of Employees:

11-50

Last Funding Date:

2016-09-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai